DIFFUSE LARGE B-CELL LYMPHOMA STAGE II

DIFFUSE LARGE B-CELL LYMPHOMA STAGE II was reported 64 times

DIFFUSE LARGE B-CELL LYMPHOMA STAGE II is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dopamine-2 Receptor Antagonist [EPC] 6 0.0008
1 Alkylating Drug [EPC] 21 0.0001
2 Nitrofuran Antibacterial [EPC] 1 0.0001
3 Vitamin D Analog [EPC] 1 0.0001
4 Purine Antimetabolite [EPC] 5 0.0001
5 Antirheumatic Agent [EPC] 5 0.0000
6 Serotonin Reuptake Inhibitor [EPC] 4 0.0000
7 Leukocyte Growth Factor [EPC] 6 0.0000
8 Topoisomerase Inhibitor [EPC] 3 0.0000
9 Folate Analog Metabolic Inhibitor [EPC] 14 0.0000
10 CD20-directed Cytolytic Antibody [EPC] 9 0.0000
11 Interleukin-17A Antagonist [EPC] 1 0.0000
12 Aromatase Inhibitor [EPC] 3 0.0000
13 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
14 Aminosalicylate [EPC] 2 0.0000
15 Microtubule Inhibitor [EPC] 3 0.0000
16 Corticosteroid [EPC] 22 0.0000
17 Tumor Necrosis Factor Blocker [EPC] 17 0.0000
18 Nitroimidazole Antimicrobial [EPC] 1 0.0000
19 Platinum-based Drug [EPC] 4 0.0000
20 Nucleoside Metabolic Inhibitor [EPC] 4 0.0000
21 Tetracycline-class Drug [EPC] 1 0.0000
22 beta-Adrenergic Blocker [EPC] 4 0.0000
23 Atypical Antipsychotic [EPC] 5 0.0000
24 Parathyroid Hormone Analog [EPC] 1 0.0000
25 Fluoroquinolone Antibacterial [EPC] 1 0.0000
26 Osmotic Laxative [EPC] 2 0.0000
27 Azole Antifungal [EPC] 1 0.0000
28 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
29 Mood Stabilizer [EPC] 1 0.0000
30 Anti-epileptic Agent [EPC] 1 0.0000
31 Opioid Agonist [EPC] 1 0.0000
32 Proton Pump Inhibitor [EPC] 2 0.0000
33 GLP-1 Receptor Agonist [EPC] 1 0.0000
34 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
35 Benzodiazepine [EPC] 1 0.0000